Biocryst Pharmaceuticals buy StockNews.com
Start price
28.06.25
/
50%
€7.92
Target price
28.06.26
-
Performance (%)
9.79%
End price
29.06.26
€8.70
Summary
This prediction ended on 29.06.26 with a price of €8.70. With a performance of 9.79%, the BUY prediction by StockNews_com for Biocryst Pharmaceuticals closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 11.608% | 11.608% | 19.680% |
| iShares Core DAX® | 1.001% | 4.831% | 8.149% |
| iShares Nasdaq 100 | 2.702% | -1.720% | 26.924% |
| iShares Nikkei 225® | 3.519% | -3.506% | 48.064% |
| iShares S&P 500 | 1.766% | 1.273% | 23.577% |
Comments by StockNews_com for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten